Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 Diabetes for more than 12 months~* Currently treated with glucose lowering tablets or insulin~* HbA1c: 7.0-12.0%

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).